Biochemistry of protein kinase reactions in the prostate in relation to androgen action
Ahmed, K.; Wilson, M.J.; Goueli, S.A.
Progress in Clinical and Biological Research 75a: 55-74
1981
ISSN/ISBN: 0361-7742 PMID: 6280200 Document Number: 171920
Document emailed within 1 workday
Related Documents
Shimazaki, J. 1998: Development and progression of prostate cancer in relation with androgen dependency Nihon Rinsho. Japanese Journal of Clinical Medicine 56(8): 1953-1958Simarro, M.; Calvo, J.; Vilà, J.M.; Places, L.; Padilla, O.; Alberola-Ila, J.; Vives, J.; Lozano, F. 1999: Signaling through CD5 involves acidic sphingomyelinase, protein kinase C-zeta, mitogen-activated protein kinase kinase, and c-Jun NH2-terminal kinase Journal of Immunology 162(9): 5149-5155
Krongrad, A.; Bai, G. 1994: c-fos promoter insensitivity to phorbol ester and possible role of protein kinase C in androgen-independent cancer cells Cancer Research 54(23): 6073-6077
Postnov, I.V.; Kravtsov, G.M.; Kotelevtsev, I.V.; Dulin, N.O.; Postnov, I.Iu. 1987: Changes in erythrocyte volume in relation to characteristics of protein phosphorylation of the membrane cytoskeleton in hypertension: role of protein kinase C Kardiologiia 27(8): 60-65
Liu, B.-d.; Feng, Q.-q.; Gu, X.; Lu, D.; Li, W. 2015: Effects of triptolide on the expression of androgen receptor in human prostate LNCaP cells and its mechanism of action Yao Xue Xue Bao 50(10): 1246-1251
Mostaghel, E.A.; Lin, D.W.; Amory, J.K.; Wright, J.L.; Marck, B.T.; Nelson, P.S.; Matsumoto, A.M.; Bremner, W.J.; Page, S.T. 2012: Impact of male hormonal contraception on prostate androgens and androgen action in healthy men: a randomized, controlled trial Journal of Clinical Endocrinology and Metabolism 97(8): 2809-2817
Presek, P.; Glossmann, H.; Eigenbrodt, E.; Schoner, W.; Rübsamen, H.; Friis, R.R.; Bauer, H. 1980: Similarities between a phosphoprotein (pp60src)-associated protein kinase of Rous sarcoma virus and a cyclic adenosine 3':5'-monophosphate-independent protein kinase that phosphorylates pyruvate kinase type M2 Cancer Research 40(5): 1733-1741
Pettaway, C.A. 1999: Racial differences in the androgen/androgen receptor pathway in prostate cancer Journal of the National Medical Association 91(12): 653-660
Izbicka, E.; MacDonald, J.R.; Davidson, K.; Lawrence, R.A.; Gomez, L.; Von Hoff, D.D. 1999: 5,6 Dihydro-5'-azacytidine (DHAC) restores androgen responsiveness in androgen-insensitive prostate cancer cells Anticancer Research 19(2a): 1285-1291
Bastos, D.A.; Dzik, C.; Rathkopf, D.; Scher, H.I. 2014: Expanding androgen- and androgen receptor signaling-directed therapies for castration-resistant prostate cancer Oncology 28(8): 693-699
Koivisto, P.; Kononen, J.; Palmberg, C.; Tammela, T.; Hyytinen, E.; Isola, J.; Trapman, J.; Cleutjens, K.; Noordzij, A.; Visakorpi, T.; Kallioniemi, O.P. 1997: Androgen receptor gene amplification: a possible molecular mechanism for androgen deprivation therapy failure in prostate cancer Cancer Research 57(2): 314-319
Gu, Y.; Kim, K-Hong.; Ko, D.; Srivastava, S.; Moul, J.W.; McLeod, D.G.; Rhim, J.S. 2005: Androgen and androgen receptor antagonist responsive primary African-American benign prostate epithelial cell line Anticancer Research 25(1a): 1-8
Amler, L.C.; Agus, D.B.; LeDuc, C.; Sapinoso, M.L.; Fox, W.D.; Kern, S.; Lee, D.; Wang, V.; Leysens, M.; Higgins, B.; Martin, J.; Gerald, W.; Dracopoli, N.; Cordon-Cardo, C.; Scher, H.I.; Hampton, G.M. 2000: Dysregulated expression of androgen-responsive and nonresponsive genes in the androgen-independent prostate cancer xenograft model CWR22-R1 Cancer Research 60(21): 6134-6141
Kadiri, C.; Cherqui, G.; Masliah, J.; Rybkine, T.; Etienne, J.; Béréziat, G. 1990: Mechanism of N-formyl-methionyl-leucyl-phenylalanine- and platelet-activating factor-induced arachidonic acid release in guinea pig alveolar macrophages: involvement of a GTP-binding protein and role of protein kinase A and protein kinase C Molecular Pharmacology 38(3): 418-425
Ostrowska, A. 1999: Various effects of protein kinase a action Postepy Biochemii 45(3): 202-210
Williams, R.T.; Carbonaro-Hall, D.A.; Hall, F.L. 1992: Co-purification of p34cdc2/p58cyclin A proline-directed protein kinase and the retinoblastoma tumor susceptibility gene product: interaction of an oncogenic serine/threonine protein kinase with a tumor-suppressor protein Oncogene 7(3): 423-432
Durocher, Y.; Chapdelaine, A.; Chevalier, S. 1989: Tyrosine protein kinase activity of human hyperplastic prostate and carcinoma cell lines PC3 and DU145 Cancer Research 49(17): 4818-4823
Gao, J.; Isaacs, J.T. 1998: Development of an androgen receptor-null model for identifying the initiation site for androgen stimulation of proliferation and suppression of programmed (apoptotic) death of PC-82 human prostate cancer cells Cancer Research 58(15): 3299-3306
Moruzzi, M.S.; Piccinini, G.; Monti, M.G.; Tadolini, B. 1989: Mechanism of polyamine action on the activation process of protein kinase C Italian Journal of Biochemistry 38(4): 309A-310A
Chinoy, M.R.; Chinoy, N.J. 1983: Differential androgen requirements of proximal and distal vas deferens of albino rats and possible potentiation of androgen action by ascorbic acid Indian Journal of Experimental Biology 21(6): 335-338